IL6R and obstructive sleep apnea syndrome: Because soluble gp130 is directly involved in attenuating harmful inflammatory trans-signaling by binding both the soluble and membrane isoforms of IL6R, the dramatic reductions observed in gp130 in OSA patients are likely to be harmful, increasing neuroinflammation, neurodegeneration, and ND risk [78].